Molecular elimination of the minimal residual Ph1 clone with IFNα in CML
- 29 February 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 339 (8792) , 557-558
- https://doi.org/10.1016/0140-6736(92)90383-e
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaBlood, 1991
- Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1991
- ELIMINATION BY INTERFERON-ALPHA OF MALIGNANT CLONE IN CHRONIC MYELOID LEUKAEMIAThe Lancet, 1989
- Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.Proceedings of the National Academy of Sciences, 1988
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemiaBlood, 1987